Hamlet Pharma AB (HAMLET-B)

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Linnane Pharma AB Chief Executive Officer (CEO)/Managing Directory Officer
Transaction date
Purchase
Price
413.99
Quantity 42,255
Value SEK903,527
Jakob Testad Chief Executive Officer (CEO)/Managing Directory Officer
Transaction date
Sale
Price
164.15
Quantity 44,839
Value SEK1,334,936
Ulla Cecilia Trägårdh Member of the Board of Directors Director
Transaction date
Purchase
Price
187.75
Quantity 2,745
Value SEK4,442,204
Mats Otto Persson Chief Executive Officer (CEO)/Managing Directory Officer
Transaction date
Purchase
Price
6.50
Quantity 10,000
Value SEK65,000
Transaction date
Purchase
Price
60,000.00
Quantity 10,000
Value SEK600,000,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2023-05-29 2023-05-26 B Purchase

Chief Executive Officer (CEO)/Managing Directory

Officer
42,255
413.99
SEK903,527
42,255 413.99 SEK903,527
2023-04-28 2023-04-26 S Sale

Chief Executive Officer (CEO)/Managing Directory

Officer
44,839
164.15
SEK1,334,936
44,839 164.15 SEK1,334,936
2022-01-19 2022-01-18 B Purchase

Member of the Board of Directors

Director
2,745
187.75
SEK4,442,204
2,745 187.75 SEK4,442,204
2021-07-26 2021-07-23 B Purchase

Chief Executive Officer (CEO)/Managing Directory

Officer
10,000
6.50
SEK65,000
10,000 6.50 SEK65,000
2017-05-24 2017-05-24 B Purchase

VDHa

10,000
60,000.00
SEK600,000,000
10,000 60,000.00 SEK600,000,000